DuChemBio Co, LTD
KOSDAQ
₩6,130.00
+0.49%
Delayed · cached 15 min
Fair value analysis
176750
DuChemBio Co, LTD
₩6,130.00
Close used for this calculation
₩4,227.49Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
39/100
Quality radar
Consensus fair value
₩4,227.49
Above FV▼ -31.0% against the close used
Model range ₩2,391.72 – ₩6,010.24
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩2,391.72Fair value₩4,227.49Bull₩6,010.24
FairClose
52-week traded range
52W low ₩5,440.0052W high ₩11,680.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
DuChemBio Co, LTD closed at ₩6,130.00, 45.0% above the consensus fair value of ₩4,227.49 drawn from 7 valuation models.
Financial DNA score 39/100 — Average. P/E of 26.8x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩6,010.24
-2.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩2,991.24
-51.2%
√(22.5 × EPS × BVPS)
EPS=229, BVPS=1736.54 · outside Graham range (P/E 26.8, P/B 3.5) — asset-light, treat as a rough floor
P/E Fair Value
₩4,580.00
-25.3%
EPS × 20x (sector P/E)
EPS=229, Sector P/E=20x
EV/EBITDA
₩2,391.72
-61.0%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=7.44B
Book Value (P/B)
₩2,520.47
-58.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=1736.54, ROE=13.2%, g=3%, r=10%
Reverse DCF
₩6,130.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 11.1% | Historical: 0%
Margin of Safety
₩3,395.37
-44.6%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=4527.16, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.